About the company
Advancements in healthcare and medicine are moving at a blistering pace, with a promising pipeline of innovative drugs on the horizon that are more targeted, personalized, and effective than ever before. Cytiva, now with the Life Sciences business of Pall Corporation, brings a depth and breadth of expertise, technologies, and services that accelerate the development and commercialization of these life-changing therapies so they can be delivered quickly and safely to the patients that need them. See what we do in this video.
Cytiva’s team of nearly 16,000 associates in more than 40 countries is driven to use their expertise and talent to achieve better flexibility, capacity, and efficiency for customers. Our broad and deep portfolio of tools and technologies, global scale, and best-in-class service provides critical support from discovery to delivery, for customers spanning researchers, emerging biotech, large-scale biopharma and contract manufacturers.
With a rich heritage tracing back over two hundred years, Cytiva joined the Danaher family of global science and technology businesses in 2020.